<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-18T20:17:46+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>基药数量扩到900？重点考虑传染病、肿瘤药？这些调整信号对药企意味着什么？</title>
    <updated>2020-11-18T19:06:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/N_I_i3ElC5W3BjDBB5NZvQ</id>
    <link href="https://mp.weixin.qq.com/s/N_I_i3ElC5W3BjDBB5NZvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>京东健康与一心堂达成战略合作 打造“互联网+医药零售”合作新样板</title>
    <updated>2020-11-18T19:06:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/eNwVfgtKubIf5h6-gDWXSQ</id>
    <link href="https://mp.weixin.qq.com/s/eNwVfgtKubIf5h6-gDWXSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创立5个月估值65亿，碾压亚盛、华领、歌礼一众新锐，为什么？</title>
    <updated>2020-11-18T19:06:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/HupnwDnfNUYnlyDCYJbMyQ</id>
    <link href="https://mp.weixin.qq.com/s/HupnwDnfNUYnlyDCYJbMyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全新医疗健康公司晖致正式成立 致力于满足全球不断变化的医疗需求</title>
    <updated>2020-11-18T19:06:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/ZdT19HQGARCJEc8pEsNFig</id>
    <link href="https://mp.weixin.qq.com/s/ZdT19HQGARCJEc8pEsNFig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2元起拍应收款，董事长辞职之后这家药企发生了什么？</title>
    <updated>2020-11-18T19:06:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/GMdlMIDISAXYjdny0ukZPg</id>
    <link href="https://mp.weixin.qq.com/s/GMdlMIDISAXYjdny0ukZPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“叫板”辉瑞？Moderna新冠疫苗有效性、稳定性双重碾压？</title>
    <updated>2020-11-17T21:58:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/KrZpP4uI8fFrjUJjscgzYQ</id>
    <link href="https://mp.weixin.qq.com/s/KrZpP4uI8fFrjUJjscgzYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>加码创新产品，强生全视双管线布局眼科全生命周期</title>
    <updated>2020-11-17T21:58:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/N_J5iG_KwF_CH2NlbutzFQ</id>
    <link href="https://mp.weixin.qq.com/s/N_J5iG_KwF_CH2NlbutzFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华、辉瑞、礼来高调进场，看药企如何玩转“互联网＋”</title>
    <updated>2020-11-17T21:58:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/La1lbicuQiqj4oBkaycpww</id>
    <link href="https://mp.weixin.qq.com/s/La1lbicuQiqj4oBkaycpww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>200讲者对话2000企业家科学家投资家：未来十年，创新将重构整个产业！</title>
    <updated>2020-11-17T21:58:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/kUEBMUSIAKlPqaLcQ8iv5A</id>
    <link href="https://mp.weixin.qq.com/s/kUEBMUSIAKlPqaLcQ8iv5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>成都威斯克公司A轮融资近3亿元用于疫苗研发</title>
    <updated>2020-11-17T21:58:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/II03ocPy0pAQcRVGbKJ_VQ</id>
    <link href="https://mp.weixin.qq.com/s/II03ocPy0pAQcRVGbKJ_VQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济市值有望超恒瑞？还有哪些有潜力冲击5000亿市值大药企？</title>
    <updated>2020-11-16T20:28:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/koNb6mk0V4rY_keGTsFMaw</id>
    <link href="https://mp.weixin.qq.com/s/koNb6mk0V4rY_keGTsFMaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田中国：洞察患者旅程痛点，创新引领患者服务新模式</title>
    <updated>2020-11-16T20:28:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/DTtvvSNtl-hDsx14PAJACg</id>
    <link href="https://mp.weixin.qq.com/s/DTtvvSNtl-hDsx14PAJACg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专业赋能 助力健康中国2030——E诺彩虹再创院外药师培训新标杆</title>
    <updated>2020-11-16T20:28:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/z_F49lBMwfH1i3W9mt9hvw</id>
    <link href="https://mp.weixin.qq.com/s/z_F49lBMwfH1i3W9mt9hvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>30年来CIN领域重磅突破性治疗品种，普那布林国际多中心3期研究达主要和所有次要终点</title>
    <updated>2020-11-16T20:28:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/A60pcupuEkURWOILNJn8dw</id>
    <link href="https://mp.weixin.qq.com/s/A60pcupuEkURWOILNJn8dw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿里减持引发的鏖战！细数爱康与美年的“爱恨纠葛”</title>
    <updated>2020-11-15T18:50:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/bjyhS5RPNn0KuBsBR4IrBQ</id>
    <link href="https://mp.weixin.qq.com/s/bjyhS5RPNn0KuBsBR4IrBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专利实战！《专利法》修改对医药创新有哪些影响？怎么破？</title>
    <updated>2020-11-15T18:50:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/BASDEU96AaiB-QJcrt8UFA</id>
    <link href="https://mp.weixin.qq.com/s/BASDEU96AaiB-QJcrt8UFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这一次，医药人在自觉捍卫创新</title>
    <updated>2020-11-14T07:20:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/UYSlBEfHReJvN2cde5QNRw</id>
    <link href="https://mp.weixin.qq.com/s/UYSlBEfHReJvN2cde5QNRw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Vlog | 创联盟，秀合作，看赛诺菲中国如何加码数字化创新</title>
    <updated>2020-11-14T07:20:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/ykAcJ8-tD_rp0J8Fur71Yg</id>
    <link href="https://mp.weixin.qq.com/s/ykAcJ8-tD_rp0J8Fur71Yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昆药集团IDH1选择性抑制剂创新药获NMPA临床试验批准</title>
    <updated>2020-11-14T07:20:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/rFU4374jIC6O3wRJZpfSNQ</id>
    <link href="https://mp.weixin.qq.com/s/rFU4374jIC6O3wRJZpfSNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国创新药对外交易4.0模式到来！礼来再次重金砸向中国创新药企，但这次是核心技术！</title>
    <updated>2020-11-13T19:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/0eyBvJh5_dqkl4NX_iDFFQ</id>
    <link href="https://mp.weixin.qq.com/s/0eyBvJh5_dqkl4NX_iDFFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>